Valuation: Attana AB

Market Cap 5.16M 514K 457K 427K 388K 734K 49.56M 740K 2M 25.27M 1.93M 1.89M 81.79M P/E 2024
-0.31x
P/E 2025 -1.11x
Enterprise Value 5.02M 500K 444K 415K 378K 713K 48.16M 719K 1.95M 24.56M 1.88M 1.84M 79.49M EV / Sales 2024
0.91x
EV / Sales 2025 8.11x
Free-Float
6.54%
Yield 2024 *
-
Yield 2025 -
1 week-33.33%
Current month-33.33%
1 month-33.33%
3 months-50.00%
6 months-75.00%
Current year-77.78%
1 week 0
Extreme 0.002
0
1 month 0
Extreme 0.002
0
Current year 0
Extreme 0.002
0.01
1 year 0
Extreme 0.002
0.02
3 years 0
Extreme 0.002
0.26
5 years 0
Extreme 0.002
1.16
10 years 0
Extreme 0.002
2.4
Manager TitleAgeSince
Chief Executive Officer - 31/03/2025
Chief Executive Officer 56 31/08/2002
Director of Finance/CFO - -
Director TitleAgeSince
Director/Board Member 56 05/08/2012
Chairman 63 30/09/2015
Director/Board Member 62 31/12/2017
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-33.33%-88.24%-99.07% 514K
+4.16%+3.04%+49.37%+94.17% 74.16B
-3.11%-3.53%+20.19%+81.44% 57.39B
+0.89%-0.63%+2.17%+36.19% 47.64B
+0.36%+0.81%+342.39%+742.40% 44.29B
-0.96%-4.50%+24.96%+35.38% 42.5B
-0.20%-0.77%+4.13%+105.50% 40.71B
-0.54%+2.93%+9.31%+50.41% 30.97B
-2.68%+2.92%+29.33%+22.72% 28.53B
+0.05%-1.64%-8.14%-11.37% 24.34B
Average -0.20%-3.86%+38.55%+105.78% 39.05B
Weighted average by Cap. +0.12%-0.84%+56.96%+138.26%

Financials

2024 2025
Net sales 4.1M 409K 363K 339K 309K 583K 39.41M 588K 1.59M 20.09M 1.54M 1.5M 65.04M 2.47M 246K 219K 204K 186K 351K 23.74M 355K 960K 12.11M 926K 906K 39.19M
Net income -12.78M -1.27M -1.13M -1.06M -962K -1.82M -123M -1.83M -4.96M -62.55M -4.78M -4.68M -202M -10.5M -1.05M -930K -869K -790K -1.49M -101M -1.51M -4.08M -51.42M -3.93M -3.85M -166M
Net Debt 1.17M 117K 104K 96.84K 88.14K 166K 11.24M 168K 455K 5.73M 438K 429K 18.56M -145K -14.5K -12.88K -12.03K -10.95K -20.67K -1.4M -20.86K -56.45K -712K -54.44K -53.26K -2.3M
Logo Attana AB
Attana AB is a Sweden-based biotechnology company specializing in in vitro characterization of molecular interactions mimicking in vivo conditions. The Company develops proprietary label-free biosensors, based on the Quartz Crystal Microbalance (QCM) technology, for biochemical, crude, sera and cell-based assays. Its products and research services are used by pharmaceutical and biotechnology companies to quality control the production line of a biological pharmaceutical or gain insight into advanced dynamic features of target molecules, as well as by academic institutions within the life sciences. Attana’s biosensors are used to determine specificity, kinetics and affinity, among other binding characteristics of biomolecules and macrostructures of varying species such as cells, antibodies, proteins, viruses and bacteria.
Employees
6
Date Price Change Volume
02/10/26 SEK 0.002000 0.00% 12,286,334
01/10/26 SEK 0.002000 -33.33% 11,383,764
30/09/26 SEK 0.003000 0.00% 9,964,972
29/09/26 SEK 0.003000 0.00% 1,424,086
28/09/26 SEK 0.003000 0.00% 3,180,021
  1. Stock Market
  2. Stocks
  3. ATANA Stock